These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8620462)

  • 21. Aromatase inhibition in JAr choriocarcinoma cells by 7alpha-arylaliphatic androgens.
    Brueggemeier RW; Gilbert NE; Gu X; O'Reilly JM; Lovely CJ
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):73-7. PubMed ID: 9328212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of rat Leydig tumor (R2C) and human hepatoma (HEPG2) cells to evaluate potential inhibitors of rat and human steroid aromatase.
    Doody KM; Murry BA; Mason JI
    J Enzyme Inhib; 1990; 4(2):153-8. PubMed ID: 1965908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.
    Brodie AM; Longcope C
    Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
    Bartsch W; Klein H; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1987; 27(1-3):557-64. PubMed ID: 2447391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 4-hydroxyandrostenedione on murine Leydig tumor cell steroidogenesis.
    Zimniski SJ; Brandt ME; Melner MH; Brodie AM; Puett D
    Cancer Res; 1991 Jul; 51(14):3663-8. PubMed ID: 2065323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the aromatase inhibitor 4-hydroxyandrostene-3,17-dione progesterone synthesis by human luteal cells.
    Devoto L; Vega M; Castro O; Kohen P
    Fertil Steril; 1991 May; 55(5):922-6. PubMed ID: 2022270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans.
    Koos RD; LeMaire WJ; Hung TT; Brodie AM
    Steroids; 1985 Feb; 45(2):143-50. PubMed ID: 4089916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid aromatization by a small particle fraction from porcine ovaries.
    Kautsky MP; Hagerman DD
    Steroids; 1976 Aug; 28(2):247-59. PubMed ID: 973238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative determination of 4-hydroxy-4-androstene-3,17-dione (4-OHA), a potent aromatase inhibitor, in human plasma, using isotope dilution mass spectrometry.
    Guarna A; Moneti G; Prucher D; Salerno R; Serio M
    J Steroid Biochem; 1989 May; 32(5):699-702. PubMed ID: 2739410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results.
    Habenicht UF; Schwarz K; Schweikert HU; Neumann F; el Etreby MF
    Prostate; 1986; 8(2):181-94. PubMed ID: 2419882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain.
    Wozniak A; Holman SD; Hutchison JB
    J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: an analog of formestane.
    Sharma SK; Zheng W; Joshua AV; Abrams DN; McEwan AJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5563-6. PubMed ID: 18815032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of estrogens in the regulation of granulosa cell aromatase activity.
    Daniel SA; Armstrong DT
    Can J Physiol Pharmacol; 1983 May; 61(5):507-11. PubMed ID: 6411308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Product of aromatase activity in intact LNCaP and MCF-7 human cancer cells.
    Castagnetta LA; Granata OM; Bellavia V; Amodio R; Scaccianoce E; Notarbartolo M; Follari MR; Miceli MD; Carruba G
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):287-92. PubMed ID: 9365203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.